Literature DB >> 31668650

Anti-PD-1 immunotherapy in advanced esophageal squamous cell carcinoma: A long-awaited breakthrough finally arrives.

Hung-Yang Kuo1, Jhe-Cyuan Guo2, Chih-Hung Hsu3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31668650     DOI： 10.1016/j.jfma.2019.10.010

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN： 0929-6646            Impact factor:   3.282


× No keyword cloud information.
  7 in total

1.  Identification of immunophenotypes in esophageal squamous cell carcinoma based on immune gene sets.

Authors:  Danlei Song; Yongjian Wei; Yuping Hu; Yueting Sun; Min Liu; Qian Ren; Zenan Hu; Qinghong Guo; Yuping Wang; Yongning Zhou
Journal:  Clin Transl Oncol       Date:  2022-01-31       Impact factor: 3.405

2.  Laminin γ2-mediating T cell exclusion attenuates response to anti-PD-1 therapy.

Authors:  Lei Li; Jia-Ru Wei; Jun Dong; Qing-Guang Lin; Hong Tang; Yong-Xu Jia; Wanlin Tan; Qing-Yun Chen; Ting-Ting Zeng; Shan Xing; Yan-Ru Qin; Ying-Hui Zhu; Yan Li; Xin-Yuan Guan
Journal:  Sci Adv       Date:  2021-02-03       Impact factor: 14.136

3.  A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909).

Authors:  Yan Zheng; Xian-Ben Liu; Hai-Bo Sun; Jinliang Xu; Sining Shen; Yu-Feng Ba; Ming Yan; Zimin Qin; Bao-Xing Liu; Zong-Fei Wang; Shi-Lei Liu; Rui-Xiang Zhang; Pei-Nan Chen; Guang-Hui Liang; Dongfeng Yuan; Zhen-Xuan Li; Qi Liu; Hao-Ran Wang; Hao-Miao Li; Hongwei Lv; Xiaochao Ma; Jianping Zhu; Yong-Kui Yu; Wen-Qun Xing
Journal:  Ann Transl Med       Date:  2021-01

4.  Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment.

Authors:  Yingxia Zheng; Zheyi Chen; Yichao Han; Li Han; Xin Zou; Bingqian Zhou; Rui Hu; Jie Hao; Shihao Bai; Haibo Xiao; Wei Vivian Li; Alex Bueker; Yanhui Ma; Guohua Xie; Junyao Yang; Shiyu Chen; Hecheng Li; Jian Cao; Lisong Shen
Journal:  Nat Commun       Date:  2020-12-08       Impact factor: 14.919

5.  Identification of prognostic biomarkers associated with tumor microenvironment in ceRNA network for esophageal squamous cell carcinoma: a bioinformatics study based on TCGA database.

Authors:  Danlei Song; Yongjian Wei; Yuping Hu; Xia Chen; Ya Zheng; Min Liu; Yuping Wang; Yongning Zhou
Journal:  Discov Oncol       Date:  2021-11-01

6.  Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Catrcinoma by Inhibiting IL-6 Signaling Pathway.

Authors:  Yao Lu; Dao Xin; Lulu Guan; Mengli Xu; Yalan Yang; Yu Chen; Yuanyuan Yang; Andrea Wang-Gillam; Li Wang; Shanggang Zong; Feng Wang
Journal:  Front Oncol       Date:  2021-11-22       Impact factor: 6.244

7.  B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma.

Authors:  Jhe-Cyuan Guo; Chia-Lang Hsu; Yen-Lin Huang; Chia-Chi Lin; Ta-Chen Huang; I-Chen Wu; Chen-Yuan Lin; Ming-Yu Lien; Hung-Yang Kuo; Ann-Lii Cheng; Chih-Hung Hsu
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.